| CTRI Number |
CTRI/2021/09/036743 [Registered on: 22/09/2021] Trial Registered Prospectively |
| Last Modified On: |
21/09/2021 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
EFFICACY OF INTRATHECAL 0.5% HYBERBARIC BUPIVACAINE 5mg WITH FENTANYL 10mcg VERSUS 0.5% HYPERBARIC BUPIVACAINE 5mg WITH FENTANYL 20mcg ON LEVEL AND DEPTH OF ANAESTHESIA AND HEMODYNAMIC PARAMETERS IN PARTURIENTS UNDERGOING CESAREAN SECTION: A RANDOMISED STUDY |
|
Scientific Title of Study
|
EFFICACY OF INTRATHECAL 0.5% HYBERBARIC BUPIVACAINE 5mg WITH FENTANYL 10mcg VERSUS 0.5% HYPERBARIC BUPIVACAINE 5mg WITH FENTANYL 20mcg ON QUALITY OF ANAESTHESIA AND HEMODYNAMIC PARAMETERS IN PARTURIENTS UNDERGOING CESAREAN SECTION: A RANDOMISED STUDY |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DR RAMYASHREE S |
| Designation |
POST GRADUATE MEDICAL STUDENT |
| Affiliation |
BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INTITUTE, KR ROAD, BANGALORE
Bangalore KARNATAKA 560002 India |
| Phone |
9740499419 |
| Fax |
|
| Email |
drramyashree2012@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR RAMESH R |
| Designation |
ASSOCIATE PROFESSOR |
| Affiliation |
BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INTITUTE, KR ROAD, BANGALORE
Bangalore KARNATAKA 560002 India |
| Phone |
9844837939 |
| Fax |
|
| Email |
rameshrevanna@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
DR RAMESH R |
| Designation |
ASSOCIATE PROFESSOR |
| Affiliation |
BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INTITUTE, KR ROAD, BANGALORE
Bangalore KARNATAKA 560002 India |
| Phone |
9844837939 |
| Fax |
|
| Email |
rameshrevanna@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
| BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE-560002 |
|
|
Primary Sponsor
|
| Name |
BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE - 560002 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| DR RAMESH R |
DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE - 560002 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR RAMYASHREE S |
BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE |
DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE - 560002 Bangalore KARNATAKA |
9740499419
drramyashree2012@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| BMCRI ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O82||Encounter for cesarean delivery without indication, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 10 mcg |
INTRATHECAL INJECTION OF 0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 10 mcg, TOTAL VOLUME TO BE MADE 2 ml BY ADDING NORMAL SALINE |
| Comparator Agent |
0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 20 mcg |
INTRATHECAL INJECTION OF 0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 20 mcg, TOTAL VOLUME TO BE MADE 2 ml BY ADDING NORMAL SALINE |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Female |
| Details |
ASA CLASS II, AGED BETWEEN 18 TO 40 YEARS, POSTED FOR ELECTIVE CESAREAN SECTION |
|
| ExclusionCriteria |
| Details |
PATIENTS REFUSAL
ALLERGIC TO DRUG
OBESE
ASA CLASS III OR IV
PRE ECLAMPSIA, ECLAMPSIA, CARDIAC OR RESPIRATORY INSUFFICIENCY, TWIN GESTATION
SEVERE FETAL DISTRESS, PLACENTAL ABRUPTION, PLACENTA PREVIA, CORD PROLAPSE
CONTRAINDICATIONS FOR NEURAXIAL BLOCKADE |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| QUALITY OF ANASTHESIA - LEVEL AND DEPTH OF SENSORY AND MOTOR BLOCKADE |
BASELINE READING AND 1MIN AFTER SAB, 2MIN, 3MIN, 5MIN, 10MIN, 15MIN, 20MIN, 25MIN, 30MIN, 40MIN,50MIN, 60MIN, 75MIN, 90MIN, 105MIN, 120MIN, POSTOPERATIVELY HOURLY FOR 4 HOURS |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NO HEMODYNAMIC CHANGES OR SIDE EFFECTS |
BASELINE READING AND 1MIN AFTER SAB, 2MIN, 3MIN, 5MIN, 10MIN, 15MIN, 20MIN, 25MIN, 30MIN, 40MIN,50MIN, 60MIN, 75MIN, 90MIN, 105MIN, 120MIN, POSTOPERATIVELY HOURLY FOR 4 HOURS |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
26/09/2021 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NONE YET |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [drramyashre2012@gmail.com].
- For how long will this data be available start date provided 26-07-2023 and end date provided 26-07-2026?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Regional Anaesthesia is the preferred
technique during Lower Segment Cesarean Section. Bupivacaine is the most
commonly used local anaesthetic agent in spinal anaesthesia. Opioids
such as fentanyl are commonly used as intrathecal adjuvants to improve the
quality of intraoperative analgesia and prolonged post-operative
analgesia. The rapid onset of sympathetic
blockade and subsequent hypotension remains a major clinical
concern. Hypotension leads to nausea, vomiting and neonatal morbidity by
reducing uteroplacental blood flow. Lowering the dose of intrathecal
bupivacaine by using fentanyl as adjuvant can be used to maintain better
hemodynamic stability, lesser requirement of vasopressors, provide better
analgesia, reduced Post-Operative Nausea and Vomiting.
This study is undertaken to study the
effect of Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 10mcg vs of Hyperbaric
Bupivacaine 0.5% 5mg with fentanyl 20mcg in spinal anaesthesia on hemodynamic
changes, onset, level, duration and speed of regression of Sensory and
Motor blockade in Parturients undergoing Lower Segment Caesarean Section.
Our study is Randomised Controlled
study which will be conducted in Bangalore Medical College And Research
Institute, Bangalore. It will be conducted on 100 participants, 50
in Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 10mcg group and 50
in Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 20mcg.
Intraoperatively Hemodynamic variables
and level and depth of anaesthesia will be recorded every minute for first five
minutes, at 5 minutes for next half an hour after the administration of
subarachnoid block and every 10 minutes thereafter up to 120 minutes after the
block. Postoperatively patient will be monitored every 1hr for the first
4hours. Side effects such as hypotension, bradycardia, shivering, nausea,
vomiting, pruritis, respiratory depression and ECG changes will be
recorded and accordingly managed. |